Oct
2026
Fiera Milano, Italy
Visit us
stand 18D78, Finished Dosage & Formulation

Axa Parenterals Ltd

Exhibitor at CPHI Milan 2026
About Us

Axa Parenterals Limited (APL) and it’s 100% subsidiary Heilsa Life Sciences (HLS) has applied for EUGMP. APL with 4 Rommelag filling machine  &  PIC/S, WHO-GMP approval is exporting in 61 countries. APL is in respules, single use eye drop (Unims), multidose eye drops and LVP. HLS is into manufacturing of General Injectable Vial–Emulsion, Liposomal and lyophilized; PFS & ampoules. Key Products-Propofol, Liposomal amphotericin B, Enoxaparin, Heparin, Levetiracetam, Milirinone,  Pantoprazole-lyophilized. We  seek CDMO/Marketing alliance in Europe and around globe.

  • Country/Region:
    India
  • On CPHI since:
    2019
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Contact info
  • Puhana Chowk ,Vill:Kishnapur- Jamalpur, Dist : Haridwar ,, 247669, Roorkee , Uttarakhand, India
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 18D78, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

Axa Parenterals Ltd Resources (1)